Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Researchers create a comprehensive map of how complex networks of genes function together

Researchers create a comprehensive map of how complex networks of genes function together

11 Jul 2022
The interplay of family history and genome-wide polygenic risk scores across 24 common diseases

The interplay of family history and genome-wide polygenic risk scores across 24 common diseases

11 Jul 2022
Study sheds light on cell type-specific biomarkers of melanoma

Study sheds light on cell type-specific biomarkers of melanoma

10 Jul 2022
Childhood physical abuse victims more likely to experience poor physical and mental health

Childhood physical abuse victims more likely to experience poor physical and mental health

7 Jul 2022
Low doses of a less commonly used drug may be a better treatment option for gout

Low doses of a less commonly used drug may be a better treatment option for gout

7 Jul 2022
Scientists discover a key starting point for inhibiting inflammation in psoriasis and psoriatic arthritis

Scientists discover a key starting point for inhibiting inflammation in psoriasis and psoriatic arthritis

6 Jul 2022
Study results underscore the challenges in treating interstitial pneumonia with autoimmune features

Study results underscore the challenges in treating interstitial pneumonia with autoimmune features

5 Jul 2022
How does obesity affect the immune system?

How does obesity affect the immune system?

4 Jul 2022
Stopping a pervasive bacterium that makes millions sick each year

Stopping a pervasive bacterium that makes millions sick each year

1 Jul 2022
New machine learning method may improve the identification of genes that cause diseases

New machine learning method may improve the identification of genes that cause diseases

28 Jun 2022
CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

27 Jun 2022
CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

27 Jun 2022
Study finds higher risk of premature death among patients with pediatric onset immune-mediated inflammatory disease

Study finds higher risk of premature death among patients with pediatric onset immune-mediated inflammatory disease

26 Jun 2022
COVID-19 outcomes improved for SARDs patients through Omicron wave

COVID-19 outcomes improved for SARDs patients through Omicron wave

22 Jun 2022
Binghamton faculty member receives $2.3 million NIH grant for research on ’smart’ knee replacements

Binghamton faculty member receives $2.3 million NIH grant for research on ’smart’ knee replacements

21 Jun 2022
Study examines trends in life expectancy in the U.S. at county level

Study examines trends in life expectancy in the U.S. at county level

16 Jun 2022
Unique 3D printed system for wide-scale production of stem cells

Unique 3D printed system for wide-scale production of stem cells

16 Jun 2022
At a Bay Area ‘test-to-treat’ site, few takers for free antivirals

At a Bay Area ‘test-to-treat’ site, few takers for free antivirals

16 Jun 2022
Recently born generations of older adults more likely to have multiple chronic health conditions

Recently born generations of older adults more likely to have multiple chronic health conditions

13 Jun 2022
Risk of severe COVID-19 in adults with immune-mediated inflammatory diseases and those on immune-modifying therapies

Risk of severe COVID-19 in adults with immune-mediated inflammatory diseases and those on immune-modifying therapies

13 Jun 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback